Breast Cancer InFocus | Roche Science

Welcome to Breast Cancer InFocus, Roche's Breast Cancer Medical Education Programme. Where you can browse our collection of CPD accredited* educational videos and gain invaluable insights from leading healthcare professionals.

A Clinical Dialogue with Professor Stephen Johnston and Professor Mark Beresford

Professors Stephen Johnston and Mark Beresford delve into key patient factors when considering treatment choices for first line (1L) oestrogen receptor positive (ER+) metastatic breast cancer (mBC) and share crucial insights through various case studies to understand treatment approaches in this setting.

Professors Stephen Johnston and Mark Beresford explore important patient factors in managing the 1L treatment of metastatic ER+ BC

“In this video we are going to discuss the various factors we look at in making decisions about the management of ER positive mBC in the 1L setting” watch Professor Stephen Johnston and Professor Mark Beresford discuss this patient focused topic and how it can influence decision making in 1L metastatic ER+ BC

Treatment choices for 1L metastatic ER+ BC patients, following 5 years of adjuvant aromatase inhibitor (AI)

Through a case study based conversation, Professors Stephen Johnston and Mark Beresford discuss treatment choices for 1L metastatic ER+ BC patients, following 5 years of adjuvant aromatase inhibitor (AI)

Treatment choices for 1L metastatic ER+ BC patients, who relapsed on adjuvant aromatase inhibitor (AI), after previously receiving CDK4/6 inhibitor + AI

In this short video, Professors Stephen Johnston and Mark Beresford use case studies to guide us through treatment choices for 1L metastatic ER+ BC patients, who relapsed on adjuvant aromatase inhibitor (AI), after previously receiving CDK4/6 inhibitor + AI

Delivering Genomic Testing in Breast Cancer

Watch Professor Ellen Copson along with other leading experts, discuss a range of topics related to delivering Genomic testing in Breast Cancer.

The fundamentals of genomic testing in breast cancer with Professor Ellen Copson

Professor Ellen Copson explores how genomic testing has revolutionised our understanding of breast cancer

Working with GLHs: Practical guidance for success with Professor Matt Krebs

Dr Matt Krebs provides top tips for optimising and requesting genomic testing

Interpreting liquid biopsy reports with Prof Ellen Copson and Dr Matt Krebs

Dr Matt Krebs describes how to interpret genomic reports using real-world examples

Implementing liquid biopsy: Learnings from lung cancer with Professor Alastair Greystoke ann Professor Ellen Copson

Professor Alastair Greystoke and Professor Ellen Copson discuss how learnings from lung cancer can optimise uptake in breast cancer

Delivering genomic testing in breast cancer: Expert perspectives and learnings with Professor Ellen Copson, Dr Matt Krebs and Professor Alastair Greystoke

Our expert panel discuss genomics in practice; from fundamentals to implementation and interpretation

Your local Medical Affairs Partner can offer breast cancer related educational sessions. We can do this in-person or virtually, as a 1:1 or group session.

Click the button below to open an email to claim your CPD certificate.

Claim your CPD certificate

*Roche remunerates CPD certification services for accreditation of this training.

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. You can also report via the free Yellow Card app available from the Apple App Store or Google Play Store. Adverse events should also be reported to Roche Products Ltd. Please contact Roche Drug Safety Centre by emailing welwyn.uk_dsc@roche.com or calling +44 (0)1707 367554.